Neuronetics (STIM) Total Non-Current Liabilities (2017 - 2026)
Neuronetics (STIM) posted quarterly Total Non-Current Liabilities of $108.3 million for Q1 2026, up 142.92% quarter-over-quarter from $44.6 million in Q2 2018.
Neuronetics (STIM) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has reported Total Non-Current Liabilities for 3 consecutive years, with $108.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $108.3 million; the TTM figure through Mar 2026 stood at $108.3 million (changed N/A YoY), while the FY2017 annual figure was $44.0 million, changed N/A from the prior year.
- Total Non-Current Liabilities rose to $108.3 million in Q1 2026 per STIM's latest filing, from $44.6 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $108.3 million in Q1 2026 and bottomed at $108.3 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.74 Bn | 197.14 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.22 Bn | 123.75 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.44 Bn | 110.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.78 Bn | 74.24 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.81 Bn | 47.56 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.98 Bn | 33.03 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.79 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.24 Bn | 22.76 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Neuronetics | 223.41 Mn | 203.98 Mn | 21.22 Mn | 109.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 109.75 Mn |
| Mar 31, 2026 | 108.31 Mn |
| Jun 30, 2018 | 44.59 Mn |
| Dec 31, 2017 | 43.98 Mn |